window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Clinical Trials,Drug Development,Rare Diseases

    Cereno taps global CRO for next big step in pulmonary hypertension drug trial

    Selection of CRO marks key milestone in advancing CS1 as [...]

    July 7, 2025
  • Biologics & Biosimilars,Clinical Trials,Drug Development,Rare Diseases

    Eleva doses first volunteers with new therapy targeting rare kidney disease

    Dosing of CPV-104 in healthy volunteers marks key milestone in [...]

    July 7, 2025
  • Clinical Development,Drug Development,Precision medicine,Rare Diseases,Technology and platforms

    Rewind Therapeutics strengthens Scientific Advisory Board with leading neurology experts as it advances remyelination therapy

    Appointments enhance clinical expertise as GPR17 modulator progresses toward trials [...]

    July 2, 2025
  • CDMOs & Manufacturing,Drug Development,Regulatory Affairs,Technology and platforms

    Thermo Fisher upgrades charged aerosol detection tech to improve complex drug analysis

    Thermo Fisher Scientific has introduced a new version of its [...]

    July 2, 2025
  • CDMOs & Manufacturing,Drug Development,Oncology,Technology and platforms

    Orano Med invests $5M to expand US radiopharma capabilities

    Orano Med has expanded its US research and development center [...]

    June 27, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Drug Development,Rare Diseases

    Game-changing £7.5M prize launches to unlock AI drug targets for ALS

    20 global teams will receive early-stage funding and access to [...]

    June 25, 2025
  • Movers & Shakers

    Phastar appoints industry veteran Billy Amzal as head of strategic consulting

    Biostatistics and real-world evidence expert joins global CRO to advance [...]

    June 25, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Clinical Trials,Regulatory Affairs

    FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development

    Regulators back AI and organ-on-a-chip technologies to modernize safety evaluation [...]

    June 24, 2025
  • Drug Development

    Lubrizol hits clinical milestone with novel solubility-enhancing excipient

    Apisolex polymer excipient formulation enters Phase 1 trials, supporting delivery [...]

    June 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding

    Ethris signs strategic collaboration with Thermo Fisher Scientific to provide access to mRNA technology platforms

    Partnership further validates Ethris’ novel technology platform based on stabilized [...]

    June 16, 2025
Previous567Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration
    Categories: Biomanufacturing, Cell & Gene Therapy, Drug Development, Manufacturing, Partnerships & Funding
  • Allucent adds strategy leaders to expand therapeutic expertise
    Categories: Clinical Development, Drug Development, Healthcare leadership, Movers & Shakers, Neurosciences, Oncology, Rare Diseases
  • Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform
    Categories: Biotech, Funding, Genetic Diseases, Mergers & Acquisitions, Research & Development, RNA Therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top